Institution:
Hofstra Northwell School of Medicine at Hofstra UniversityResearchers:
Peter Davies, PhD, and his colleagues at Hofstra Northwell School of Medicine
Impact:
The finding offers a new target for drug development that could stave off the pathological disease process.
Timeline:
2011